Anti-rat IL-8 (CINC) monoclonal antibody administration reduces ischemia-reperfusion injury in small intestine.
Tsuruma
T
T
Department of Surgery, Sapporo Medical University School of Medicine, Japan.
Yagihashi
A
A
Tarumi
K
K
Hirata
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D019743:Chemokines, CXC / Q000097:blood / Q000276:immunology; D002630:Chemotactic Factors / Q000097:blood / Q000276:immunology*; D006133:Growth Substances / Q000097:blood / Q000276:immunology*; D036341:Intercellular Signaling Peptides and Proteins; D016209:Interleukin-8 / Q000097:blood / Q000276:immunology*; D007421:Intestine, Small / Q000098:blood supply* / Q000473:pathology; D007511:Ischemia; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000378:metabolism
D000911:Antibodies, Monoclonal; D019743:Chemokines, CXC; D002630:Chemotactic Factors; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D016209:Interleukin-8; D014409:Tumor Necrosis Factor-alpha